Pelvic Inflammatory Disease
24
3
5
15
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
25%
6 trials in Phase 3/4
27%
4 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (24)
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II
Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer
The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID)
Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain
Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
Pelvic Inflammatory Disease in COVID-19 Era
Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity
First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
The Role of Novel Organisms in Acute Endometritis
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease
Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.